Adjuvant Chemotherapy for Breast Cancer in Older Adult Patients

被引：0
|
作者：
Gao, Ying [1 ,2 ]
Hao, Jie [1 ]
Zhang, Zhendong [1 ]
机构：
[1] Tianjin Union Med Ctr, Dept Breast & Thyroid Surg, Tianjin 300121, Peoples R China
[2] Tianjin Med Univ Canc Hosp, Natl Canc Clin Res Ctr, Tianjin Canc Clin Res Ctr, Dept Thyroid & Neck Canc, Tianjin 300060, Peoples R China
来源：
CLINICAL INTERVENTIONS IN AGING | 2024年 / 19卷
关键词：
breast cancer; older adult patients; chemotherapy; assessment; INTERNATIONAL SOCIETY; UPDATED RECOMMENDATIONS; EUROPEAN-SOCIETY; WOMEN; MANAGEMENT; MORTALITY; VALIDATION; TRIAL; INDEX;
D O I：
10.2147/CIA.S470262
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
Decision-making regarding adjuvant chemotherapy for older adults with breast cancer is a challenge because older adult patients often have poor physical health, frailty, and age-related comorbidities, which can compromise treatment outcome. Due to these considerations, doctors tend to use less chemotherapy for breast cancer in older adults. However, older patients in good general health could still benefit from chemotherapy. Careful benefit-risk assessment is essential to provide best care for each older adult patient. Due to a rapidly aging population, breast cancer in older adults is becoming a serious public health issue in China. In this mini review, we discuss the need, means, and tools to assess the benefits and risks of adjuvant chemotherapy in older adults with breast cancer. The contents of this review may drive decision-making with regard to the use and selection of adjuvant chemotherapy for older adult patients in China who are fit for the treatment.
引用
收藏
页码：1281 / 1286
页数：6
相关论文
共 50 条
  • [21] ADJUVANT CHEMOTHERAPY OF BREAST-CANCER PATIENTS
    QUEISSER, W
    FORTSCHRITTE DER MEDIZIN, 1980, 98 (08) : 286 - 288
  • [22] Feasibility of adjuvant chemotherapy for breast cancer patients
    Imoto, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (05) : 310 - 315
  • [23] Adjuvant chemotherapy for breast cancer in patients with schizophrenia
    Hwang, Mark
    Farasatpour, Mishel
    Williams, Campbell D.
    Margenthaler, Julie A.
    Virgo, Katherine S.
    Johnson, Frank E.
    ONCOLOGY LETTERS, 2012, 3 (04) : 845 - 850
  • [24] Adjuvant chemotherapy and prognosis in patients with breast cancer
    Kilickap, S.
    Arslan, C.
    ANNALS OF ONCOLOGY, 2009, 20 (01) : 192 - 193
  • [25] Age, and not comorbidity, is associated with adjuvant chemotherapy use in older breast cancer patients in England
    Richards, Paul
    Ward, Sue
    Morgan, Jenna
    Francis, Matthew
    Lawrence, Gill
    Wyld, Lynda
    FUTURE ONCOLOGY, 2015, 11 (04) : 20 - 21
  • [26] The Feasibility and Tolerability of Newer Chemotherapy Regimens in the Adjuvant Setting in Older Patients with Breast Cancer
    Ladwa, Rahul
    Sanmugarajah, Jasotha
    BREAST JOURNAL, 2016, 22 (02): : 244 - 246
  • [27] The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters
    Brouwers, Barbara
    Hatse, Sigrid
    Dal Lago, Lissandra
    Neven, Patrick
    Vuylsteke, Peter
    Dalmasso, Bruna
    Debrock, Guy
    Van Den Bulck, Heidi
    Smeets, Ann
    Bechter, Oliver
    Bailur, Jithendra Kini
    Kenis, Cindy
    Laenen, Annouschka
    Schoffski, Patrick
    Pawelec, Graham
    Journe, Fabrice
    Ghanem, Ghanem-Elias
    Wildiers, Hans
    ONCOTARGET, 2016, 7 (21) : 29977 - 29988
  • [28] Impact of Diabetes Mellitus on Complications and Outcomes of Adjuvant Chemotherapy in Older Patients With Breast Cancer
    Srokowski, Tomasz P.
    Fang, Shenying
    Hortobagyi, Gabriel N.
    Giordano, Sharon H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (13) : 2170 - 2176
  • [29] Standard adjuvant chemotherapy recommended for older women with breast cancer
    不详
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 872 - 872
  • [30] Adjuvant Chemotherapy in Older Women with Early Breast Cancer Comment
    Wilhelm, Martin
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (01) : 56 - 57
12345